Autofluorescence-guided Hemithyroidectomy in a Low-volume, Non-parathyroid Insitution: A Randomized Clinical Trial

NCT ID: NCT05044351

Last Updated: 2023-11-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

170 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-09-15

Study Completion Date

2023-10-16

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Parathyroid damage and inadvertent excision unfortunately happens frequently in thyroid surgery. The use of near-infrared autofluorescence (NIRAF) intraoperatively, seems to be helpful in terms of parathyroid identification and preservation.

In order to cover every aspect of the impact of NIRAF in thyroid surgery, an evaluation in low-volume, non-parathyroid centers is needed:

Aim: To investigate the impact of NIRAF on hemithyroidectomy by evaluating parathyroid identification, damage and the rate of inadvertent parathyroid excision in a low-volume, non-parathyroid institution.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients referred for hemithyroidectomy will be randomized to either:

(A) NIRAF-assisted hemithyroidectomy (Fluobeam LX) or (B) Conventional hemithyroidectomy. PTH and ionized calcium will assessed preoperatively, on postoperative day 1 (POD1) and one month following surgery. Parathyroid identification rates, rates of autoimplantation and inadvertently excised parathyroid glands will be assessed and compared.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Autofluorescence Thyroidectomy Autotransplantation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized Clinical Trial
Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Caregivers
Patients and related health care staff will be blinded for the allocated intervention until the day of surgery

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

(A): NIRAF-assisted surgery

Patients undergoing NIRAF-assisted hemithyroidectomy

Group Type EXPERIMENTAL

Fluobeam LX

Intervention Type DEVICE

See arm description

(B): Conventional surgery

Patients undergoing conventional hemithyroidectomy without NIRAF-assistance

Group Type ACTIVE_COMPARATOR

Conventional surgery without NIRAF assistance

Intervention Type OTHER

Patients undergoing conventional hemithyroidectomy without NIRAF-assistance

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Fluobeam LX

See arm description

Intervention Type DEVICE

Conventional surgery without NIRAF assistance

Patients undergoing conventional hemithyroidectomy without NIRAF-assistance

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients referred for thyroid lobectomy
* Age \> 18
* Able to understand patient information
* Able to give informed consent

Exclusion Criteria

* Completion lobectomy
* Need for accelerated surgery
* Age \< 18
* Unable to understand patient information
* Unable to give informed consent
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Regional Hospital West Jutland

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ali Abood

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Otorhinolaryngology, Regional Hospital West Jutland

Holstebro, , Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

References

Explore related publications, articles, or registry entries linked to this study.

Abood A, Rolighed L, Ovesen T, Madsen SH, Vestergaard P, Triponez F. Autofluorescence-guided hemithyroidectomy in a low-volume thyroid institution with no experience in parathyroid surgery: randomized clinical trial. Br J Surg. 2024 Apr 3;111(4):znae075. doi: 10.1093/bjs/znae075.

Reference Type DERIVED
PMID: 38573333 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Autofluorescence2.0

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.